STC and Invest Sweden have established a sourcing cooperation with Swiss VC firms.
The cooperation provides following opportunities:
- A selected group/platform of some of the most interesting Life Science investors in Switzerland and Europe with interest in Swedish Life Science companies
- Access to key decision makers and dedicated feedback on your company
- Opportunity to get short listed for in-depth discussions with venture capital funds
What are the Swiss investors looking for?
- Drug development, biotech platforms, medtech/medical device, diagnostics, therapeutics
- From start-up/seed capital to late stage investments
-From R&D, clinical studies and human proof-of-concept trials to registration trials/marketing and businesses/growth capital Investment range MEUR 0.1-30
- Innovative and leading companies in their niche
How do I participate?
Register no later than June 28th trough this
form
or
online and you will be contacted by Invest Sweden or the Swedish Trade Council with further information.
Why Swiss Venture Capital? - Switzerland constitutes an interesting VC pool
-
Even in the current down turn Swiss VC investments in Life Science show steady volumes and actually increases relative other segments
- The VCs see a problem in the low “deal flow” i.e. a lack of interesting business ventures
- The Swiss VCs invest 90% of their capital (that is to a relative high degree foreign capital) in European ventures
- Historically, however investments in Swedish entities have not been substantial
